...

Crystagen 20mg

$54.99

(5.0) (21 customer reviews)

Research Studies:

  • Facilitates analysis of peptide-DNA interactions within thymic and splenic chromatin architectures
  • Supports investigation of protein synthesis regulation in lymphocyte differentiation pathways
  • Enables research on homeostatic modulation of cytokine expression and immunomodulatory signaling
  • Useful for evaluating epigenetic regulation of cellular repair mechanisms in senescence

Quantity:

Free Shipping

In stock (can be backordered)

Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.
Buy Peptides with confidence: Stripe-powered secure checkout and major cards accepted.
Secure payment methods for buying peptides: Visa, MasterCard, AMEX, and more.

FREE Shipping on 

orders over $200

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Description

Crystagen 20mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

Key Product Details

  • Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
  • Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
  • Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
  • Produced with lot-level traceability to support research documentation and laboratory recordkeeping.

Research Documentation Context

  • Supports compound characterization in controlled laboratory settings.
  • Provides batch-specific identity and purity documentation for research review.
  • Allows lot-level traceability across laboratory documentation workflows.
  • Supports comparison of product labeling, analytical documentation, and storage information during research planning.
  • Supports analytical review of short peptide research materials within a strictly laboratory-focused context.

Specifications and Documentation

  • Certificate of Analysis: Available with batch-specific documentation where applicable.
  • Material Safety Data Sheet: Coming Soon.
  • Handling and Storage Instructions: Coming Soon.
  • Product Form: Lyophilized powder.
  • Purity Specification: ≥99% purity.
  • Intended Use: Laboratory research use only.

Crystagen 20mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

Additional information

CAS No.

N/A

Purity

≥99%

Sequence

Glu-Asp-Pro

Molecular Formula

C14H21N3O8

Molecular Weight

359.34 g/mol

Applications

Immune function research, thymic peptide studies, stress and aging immunology

Synthesis

Solid-phase synthesis

Format

Lyophilized powder

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months.

Appearance

White lyophilized powder

Safety Information

Refer to provided MSDS

There are no reviews yet.

We value your feedback. Please leave a review below:

Research Procurement Information

Buy Crystagen Online for Research | COA Guide

Researchers searching for buy Crystagen online should evaluate Crystagen as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, Crystagen COA review, purity documentation, lot traceability, product labeling, storage information, and supplier evaluation. This guide explains how to evaluate Crystagen 20mg for controlled research procurement through Pure Lab Peptides while keeping procurement language strictly limited to research-use-only documentation review.

Fast Answer: buy Crystagen online for Laboratory Research

Researchers can buy Crystagen online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Pure Lab Peptides lists Crystagen 20mg as lyophilized powder with product identity information for research documentation review.[1]

What Does “Buy Crystagen Online” Mean in a Research Context?

The phrase “buy Crystagen online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the search phrase refers to qualified researchers, laboratory buyers, research institutions, and technical procurement teams evaluating whether a Crystagen research material is documented appropriately for controlled laboratory workflows.

Research procurement is different from consumer purchasing. A laboratory buyer should assess intended-use labeling, certificate of analysis availability, lot traceability, identity documentation, method transparency, and storage information before selecting an RUO supplier. FDA guidance in the in vitro diagnostic context illustrates how research-use-only labeling is tied to intended use and marketing position, even though that guidance is not a peptide-specific purchasing rule.[2] Laboratory quality systems also emphasize documented competence, traceability, and consistent procedures when testing or calibration activities are involved.[3]

For Crystagen research-use-only procurement, online evaluation should focus on the evidence attached to the material: product identity, lot number, purity documentation, Crystagen identity testing, analytical method references, and supplier language. NIST reference-material programs illustrate the broader measurement principle that documented composition, property values, and certificates support technical confidence in laboratory materials.[4][5]

Crystagen Research Material Overview

Crystagen is presented by Pure Lab Peptides as a research-use-only short peptide material supplied as Crystagen 20mg lyophilized powder. The product page lists the sequence as Glu-Asp-Pro, the formula as C14H21N3O8, and the molecular weight as 359.34 g/mol.[1] A peptide is generally defined as a short chain of amino acids linked by peptide bonds, with common scientific definitions distinguishing peptides from larger proteins by chain length.[6]

Crystagen fits the short peptide or bioregulator research category. Published literature discusses Glu-Asp-Pro and related short peptides in model-system contexts, including studies involving lymphoid or spleen-cell research models and broader reviews of short-peptide gene-expression literature.[7][8][9] A systematic review has summarized peptide regulation of gene expression across multiple short-peptide research contexts, but that literature should be read as scientific background rather than product-use guidance.[10]

In laboratory procurement, the most relevant Crystagen supplier documentation is not a claimed biological outcome. It is the documentation package that supports identity, purity, lot traceability, product form, labeling consistency, and storage records. Short peptide research literature should be discussed as scientific context, not as product-use guidance.

Why Researchers Search “Buy Crystagen Online”

Researchers may search “buy Crystagen online” when comparing RUO product availability, batch-specific documentation, and supplier transparency. The goal is not to evaluate personal-use claims. The goal is to determine whether a supplier provides enough documentation for internal procurement records, material tracking, and research planning.

A technical buyer may search buy Crystagen to compare the compound name, amount, product form, lot-level documents, and Crystagen purity documentation across supplier pages. The same buyer may also review whether the supplier avoids language about personal outcomes, administration practices, or medical positioning. A research-oriented supplier page should make the product identity and RUO status clear, while the associated documentation should allow the receiving laboratory to match the material to the correct lot and COA.

Analytical chemistry literature supports the idea that purity, mass, impurity profile, and identity information are related but not identical quality signals. HPLC is widely used in peptide analysis and purification, while mass spectrometry and LC-MS methods are commonly discussed for synthetic peptide characterization and quality review.[11][12][13]

Research Procurement Checklist for Crystagen

  • Verify that Crystagen is labeled for research use only.
  • Review the batch-specific certificate of analysis before procurement and retain it in laboratory purchasing records.
  • Confirm that the Crystagen COA includes identity and purity documentation tied to the relevant lot.
  • Check whether HPLC, LC-MS, mass spectrometry, or another analytical method is listed for Crystagen identity testing or purity review.
  • Compare the product name, amount, lot number, and documentation for consistency across the product page, label, and COA.
  • Assess whether the supplier avoids dosing, preparation, therapeutic, diagnostic, or personal-use claims.
  • Document storage and handling information in internal laboratory records.
  • Evaluate whether lyophilized powder form matches the intended research workflow and receiving procedures.
  • Confirm that the product is not marketed for human or animal consumption.

Crystagen Quality Signals to Review Before Buying Online

When researchers buy Crystagen online for laboratory research, quality review should focus on documentation rather than claims. A concise comparison table can help procurement teams separate RUO quality signals from noncompliant sales language.

Evaluation Area What Researchers Should Review Why It Matters for RUO Procurement
RUO labeling Confirm the product is clearly labeled for research use only Helps separate research procurement from human-use positioning
COA availability Review the available batch-specific certificate of analysis Supports lot-level documentation and quality review
Purity data Look for analytical support for the stated purity Helps evaluate material consistency
Identity testing Review HPLC, LC-MS, mass spectrometry, or related identity data listed in documentation Helps confirm the material matches the listed compound
Lot traceability Match lot numbers across product and documentation Supports research recordkeeping
Product form Confirm whether the material is supplied as lyophilized powder or another documented form Supports laboratory planning
Storage information Review storage and handling documentation Helps maintain material integrity in laboratory settings
Supplier language Confirm the supplier avoids dosing, therapeutic, or personal-use claims Supports research-use-only positioning

COA, Purity, and Identity Documentation

For a Crystagen research material, the COA should be reviewed as a batch-specific technical document. A complete review looks beyond a single purity number. Researchers should check the compound name, lot number, test date, purity percentage, analytical method, identity confirmation, molecular weight, sequence or listed identity attributes, product form, storage documentation, and consistency between the product page and batch documentation.

A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. HPLC can support purity profiling and separation-based review, but peptide identity frequently benefits from mass-based analytical confirmation.[11][12] LC-MS and high-resolution mass spectrometry literature discuss the role of mass-based methods in peptide quality control, impurity identification, and structural confirmation.[13][14]

Analytical method validation and method development guidance also support the general principle that laboratory measurements should be evaluated through defined procedures, performance characteristics, and fit-for-purpose method design.[15][16] Peptide impurity literature further shows why purity review, impurity profiling, and mass-based characterization can provide complementary information rather than interchangeable conclusions.[17][18][19]

flowchart TD A[Receive product and COA] --> B{RUO labeling present?} B -- No --> C[Flag procurement gap] B -- Yes --> D{Lot number matches across label and COA?} D -- No --> E[Request batch-specific documentation] D -- Yes --> F{Identity supported by analytical method?} F -- No --> G[Request HPLC, LC-MS, or equivalent] F -- Yes --> H[Proceed to laboratory documentation and storage]

Storage and handling documentation should also be retained with procurement records. Peptide-focused laboratory recommendations discuss storage, handling, and stability considerations for peptides used in mass spectrometry-based assays, while stability reviews describe how peptide materials can be sensitive to physical and chemical factors under laboratory conditions.[20][21][22]

Research Literature Context

Crystagen appears in short-peptide research literature as Glu-Asp-Pro or EDP in model-system contexts. Some published work discusses short peptides including Crystagen in spleen-cell or lymphoid-cell research models, while other publications discuss tripeptides and short peptide bioregulators more broadly.[7][8] These papers provide research context, not instructions for using Crystagen research-use-only material.

Additional literature reviews discuss short peptides and gene-expression models. Those publications can help a laboratory understand why short peptides are discussed in scientific literature, but they do not replace compound-specific analytical documentation, Crystagen supplier documentation, or the batch-specific COA.[9][10] Molecular modeling literature involving ultrashort peptides also provides context for how short sequences may be examined computationally or experimentally, but it should not be converted into product-use claims.[23]

The evidence landscape for Crystagen is therefore best treated as a combination of product-specific documentation, peptide identity information, short-peptide literature, and analytical quality methodology. Findings should not be interpreted as product-use guidance. Short peptide research literature should be discussed as scientific context, not as product-use guidance.

Evidence Landscape

Research Area What Literature Examines Evidence Type RUO Interpretation
Compound identity Molecular structure, sequence, formula, or classification Database / analytical Supports identification, not product-use claims
Pathway or category context Short peptide and bioregulator research in model-specific literature Review / in vitro / preclinical Useful for research context, not therapeutic claims
Analytical testing Purity, identity, and batch verification HPLC / LC-MS / mass spectrometry / COA Supports documentation review
Storage and stability Material form and handling considerations Laboratory documentation Supports research workflow planning

Claim Boundary Table

Research-Safe Statement Why It Is Acceptable Non-Compliant Version to Avoid
“Crystagen is discussed in published research related to short peptide and bioregulator model systems.” Describes literature context without making a product claim “Crystagen helps with a human outcome.”
“Researchers should review COA and identity data before procurement.” Focuses on documentation and quality review “Users should buy Crystagen for results.”
“Pure Lab Peptides supplies Crystagen as a research-use-only material.” Clarifies intended use “Pure Lab Peptides supplies Crystagen for therapy.”
“The phrase buy Crystagen online is addressed as research procurement intent.” Qualifies commercial search intent “Buy Crystagen online for personal use.”
“Crystagen purity documentation and identity testing should be reviewed together.” Separates analytical documentation from unsupported outcome claims “A purity number proves everything a buyer needs to know.”

How Pure Lab Peptides Presents Crystagen

Pure Lab Peptides presents Crystagen 20mg as a research-use-only compound. The product page identifies the material as Crystagen, lists lyophilized powder as the product form, and includes sequence, formula, molecular-weight, and purity information for research documentation review.[1]

For Pure Lab Peptides Crystagen, a batch-specific COA is available, and researchers should review the Crystagen COA as part of lot-level procurement documentation. The product is positioned with a ≥99% purity claim, RUO labeling, product page documentation, storage and handling documentation, lot-level traceability, and supplier transparency. Those documentation elements are the appropriate focus for laboratory buyers evaluating Crystagen research-use-only procurement.

Review the Pure Lab Peptides Crystagen research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Teams comparing broader peptide procurement options can also review the Pure Lab Peptides research peptide collection, the Pure Lab Peptides research blog, and shipping and returns information for procurement planning.

Common Misunderstandings About Buying Crystagen Online

Misunderstanding: “Buy Crystagen online” means personal use

Buy Crystagen online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, storage records, and supplier transparency.

Misunderstanding: Published literature equals product-use guidance

Published literature can provide scientific context for Crystagen research material, but it does not create instructions for RUO materials. Short peptide publications, model-system studies, and analytical references should be read as background for research planning and documentation review, not as directions for any personal or applied use.

Misunderstanding: Purity percentage alone proves identity

A purity percentage is an important quality signal, but it does not fully establish compound identity. Researchers should evaluate Crystagen purity documentation together with identity testing, analytical method information, lot number consistency, molecular identity, product form, and batch-specific COA records.

Misunderstanding: COA documentation does not need to be batch-specific

COA documentation is most useful when it is tied to the specific lot received by the laboratory. For Crystagen supplier documentation, procurement teams should match the product name, lot number, purity information, identity data, and product form across the label, product page, and COA.

Misunderstanding: RUO labeling supports human or animal use

Research-use-only labeling does not support human or animal use. It clarifies that the material is intended for controlled laboratory research workflows. Procurement teams should reject supplier language that shifts Crystagen from documentation-based research sourcing into personal-use, diagnostic, veterinary, or therapeutic positioning.

FAQs About Buying Crystagen Online for Research

Where can researchers buy Crystagen online for laboratory research?

Researchers can buy Crystagen online for laboratory research through an RUO supplier that provides clear labeling, product identity information, batch-specific COA access, purity documentation, and supplier transparency. Pure Lab Peptides provides a Crystagen 20mg product page for reviewing RUO labeling, product details, and available batch-specific documentation.

What should researchers check before buying Crystagen online?

Before buying Crystagen online, researchers should check RUO labeling, Crystagen COA availability, lot number matching, purity documentation, identity testing, product form, storage information, and supplier language. The supplier should present Crystagen as a laboratory research material and should not position it for personal, diagnostic, therapeutic, or veterinary use.

Why does a COA matter when buying Crystagen?

A COA matters when buying Crystagen because it connects the supplied material to batch-specific analytical documentation. Researchers should review the COA for compound name, lot number, purity data, identity information, test method, and documentation consistency. The COA should be retained with internal procurement and laboratory records.

Is Crystagen intended for human or animal consumption?

Crystagen is not intended for human or animal consumption. In this article, Crystagen is discussed only as a research-use-only laboratory material. Procurement review should focus on RUO labeling, batch documentation, analytical testing, storage information, and supplier transparency, not on consumer use or biological outcomes.

What does research use only mean for Crystagen?

Research use only means Crystagen is positioned for controlled laboratory research and technical documentation review. It does not mean the material is appropriate for clinical, diagnostic, veterinary, or personal-use purposes. Qualified researchers should evaluate Crystagen through COA review, purity documentation, identity testing, and lot-level traceability.

How should published literature about Crystagen be interpreted?

Published literature about Crystagen and related short peptides should be interpreted as scientific context. It may help researchers understand how short peptides appear in model-system literature, but it should not be treated as product-use guidance. Batch-specific documentation remains essential for RUO procurement review.

Next Steps

Qualified researchers evaluating Crystagen should review product labeling, COA status, identity documentation, storage information, purity data, and supplier transparency before selecting any research-use-only material. Review the Crystagen product page for RUO labeling, purity information, and available batch-specific documentation.

References

  1. Pure Lab Peptides. “Crystagen 20mg.” Product page. Accessed 2026. https://purelabpeptides.com/buy-peptides/buy-crystagen-20mg/
  2. U.S. Food and Drug Administration. “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only.” FDA Guidance Document. 2013. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/distribution-in-vitro-diagnostic-products-labeled-research-use-only-or-investigational-use-only
  3. International Organization for Standardization. “ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories.” ISO Standard. 2017. https://www.iso.org/standard/66912.html
  4. National Institute of Standards and Technology. “Standard Reference Materials.” NIST. Accessed 2026. https://www.nist.gov/srm
  5. National Institute of Standards and Technology. “Reference Materials.” NIST. Accessed 2026. https://www.nist.gov/reference-materials
  6. National Human Genome Research Institute. “Peptide.” NHGRI Genetics Glossary. Accessed 2026. https://www.genome.gov/genetics-glossary/Peptide
  7. Chervyakova NA, Lin’kova NS, Chalisova NI, Kontsevaya EA, Trofimova SV, Khavinson VKh. “Age-related molecular aspects of immunomodulating activity of peptides in the spleen.” Advances in Gerontology. 2014;4:12-15. https://doi.org/10.1134/S2079057014010020
  8. Khavinson VK, Nikolsky IS, Nikolskaya VV, Zubov DA, Galickaya SN, Taranuha LI, Semenova Ya-MA, Lisica NA, Linkova NS, Butenko GM. “Effect of tripeptides on lymphoid and stem cells.” Bulletin of Experimental Biology and Medicine. 2011;151(6):722-725. https://pubmed.ncbi.nlm.nih.gov/22485217/
  9. Khavinson VK, Lin’kova NS, Tarnovskaya SI. “Short Peptides Regulate Gene Expression.” Bulletin of Experimental Biology and Medicine. 2016;162(2):288-292. https://pubmed.ncbi.nlm.nih.gov/27909961/
  10. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. “Peptide Regulation of Gene Expression: A Systematic Review.” Molecules. 2021;26(22):7053. https://pmc.ncbi.nlm.nih.gov/articles/PMC8619776/
  11. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. “HPLC analysis and purification of peptides.” Methods in Molecular Biology. 2007;386:3-55. https://pmc.ncbi.nlm.nih.gov/articles/PMC7119934/
  12. Prabhala BK, Mirza O, Hojrup P, Hansen PR. “Characterization of Synthetic Peptides by Mass Spectrometry.” Methods in Molecular Biology. 2015;1348:77-82. https://pubmed.ncbi.nlm.nih.gov/26424265/
  13. Zeng K, Geerlof-Vidavisky I, Gucinski A, Jiang X, Boyne MT 2nd. “Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control.” AAPS Journal. 2015;17(3):643-651. https://pmc.ncbi.nlm.nih.gov/articles/PMC4406950/
  14. Lian Z, Wang N, Tian Y, Huang L. “Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives.” Journal of the American Society for Mass Spectrometry. 2021;32(8):1852-1860. https://pubs.acs.org/doi/10.1021/jasms.0c00479
  15. U.S. Food and Drug Administration. “Q2(R2) Validation of Analytical Procedures.” FDA Guidance Document. 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q2r2-validation-analytical-procedures
  16. U.S. Food and Drug Administration. “Q14 Analytical Procedure Development.” FDA Guidance Document. 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q14-analytical-procedure-development
  17. Li M, Josephs RD, Daireaux A, Choteau T, Westwood S, Wielgosz RI. “Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry.” Analytical and Bioanalytical Chemistry. 2018;410(20):5059-5070. https://pubmed.ncbi.nlm.nih.gov/29862433/
  18. De Spiegeleer B, Vergote V, Pezeshki A, Peremans K, Burvenich CPG. “Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: The obestatin case.” Analytical Biochemistry. 2008;376(2):229-234. https://pubmed.ncbi.nlm.nih.gov/18342612/
  19. Smart SS, Mason TJ, Bennell PS, Maeji NJ, Geysen HM. “High-throughput purity estimation and characterisation of synthetic peptides by electrospray mass spectrometry.” International Journal of Peptide and Protein Research. 1996;47(1-2):47-55. https://pubmed.ncbi.nlm.nih.gov/8907499/
  20. Hoofnagle AN, Whiteaker JR, Carr SA, Kuhn E, Liu T, Massoni SA, Thomas SN, et al. “Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.” Clinical Chemistry. 2016;62(1):48-69. https://pmc.ncbi.nlm.nih.gov/articles/PMC4830481/
  21. Zapadka KL, Becher FJ, Gomes dos Santos AL, Jackson SE. “Factors affecting the physical stability of peptide therapeutics.” Interface Focus. 2017;7(6):20170030. https://pmc.ncbi.nlm.nih.gov/articles/PMC5665799/
  22. Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schoneich C, Avanti C. “Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.” Pharmaceutics. 2023;15(3):935. https://pmc.ncbi.nlm.nih.gov/articles/PMC10056213/
  23. Khavinson VK, Linkova NS, Chalisova NI, Ivko OM. “Transport of Biologically Active Ultrashort Peptides Using Molecular Modeling and Analysis of Their Interaction with Membrane Components.” International Journal of Molecular Sciences. 2022;23(14):7733. https://www.mdpi.com/1422-0067/23/14/7733

Have Questions?

Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.

0